The Cigna Group (NYSE:CI) Insider Brian C. Evanko Sells 4,795 Shares

The Cigna Group (NYSE:CI) insider Brian C. Evanko sold 4,795 shares of the company’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $345.01, for a total transaction of $1,654,322.95. Following the completion of the transaction, the insider now owns 39,923 shares of the company’s stock, valued at approximately $13,773,834.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

The Cigna Group Trading Down 0.4 %

Shares of CI stock traded down $1.21 during trading hours on Wednesday, hitting $337.59. The company had a trading volume of 1,491,454 shares, compared to its average volume of 1,617,163. The company’s fifty day moving average is $342.12 and its 200 day moving average is $332.66. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.71 and a quick ratio of 0.71. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $365.71. The stock has a market capitalization of $95.90 billion, a PE ratio of 27.73, a price-to-earnings-growth ratio of 1.03 and a beta of 0.53.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, topping the consensus estimate of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The firm had revenue of $57.25 billion for the quarter, compared to analyst estimates of $56.59 billion. During the same period in the prior year, the business posted $5.41 EPS. The business’s revenue for the quarter was up 23.2% compared to the same quarter last year. Research analysts expect that The Cigna Group will post 28.47 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th were issued a dividend of $1.40 per share. The ex-dividend date of this dividend was Tuesday, June 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.66%. The Cigna Group’s dividend payout ratio (DPR) is presently 45.98%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Baird R W raised shares of The Cigna Group to a “strong-buy” rating in a research note on Thursday, May 30th. JPMorgan Chase & Co. boosted their target price on shares of The Cigna Group from $432.00 to $435.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 12th. Morgan Stanley reissued an “overweight” rating and set a $392.00 target price (up previously from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Finally, Barclays assumed coverage on shares of The Cigna Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $393.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $376.20.

Institutional Investors Weigh In On The Cigna Group

A number of hedge funds have recently added to or reduced their stakes in CI. Norges Bank acquired a new stake in The Cigna Group during the 4th quarter worth approximately $1,006,348,000. Vanguard Group Inc. lifted its holdings in The Cigna Group by 8.1% during the 1st quarter. Vanguard Group Inc. now owns 26,793,138 shares of the health services provider’s stock worth $9,731,000,000 after buying an additional 2,017,333 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in The Cigna Group by 6.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 14,341,233 shares of the health services provider’s stock worth $5,208,593,000 after buying an additional 867,180 shares in the last quarter. Focused Investors Fund L P acquired a new stake in shares of The Cigna Group in the 1st quarter valued at $205,529,000. Finally, Cerity Partners LLC lifted its position in shares of The Cigna Group by 1,039.4% during the 4th quarter. Cerity Partners LLC now owns 590,063 shares of the health services provider’s stock worth $176,694,000 after purchasing an additional 538,274 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.